With a patent for Dai Chaplin for Oxi4503 and Fosbretabulin assigned to Angiogene???
With May 21st, 2015 as publication date??
Can someone explain what's going on?
I'd pay back the $33 million in cash to shareholders, sell the office furniture and pay that back, give up my salary and options, recommend to the other officers they do the same and try and convince Shweiterman to put the company up for sale. Would you hire Root?
Actually I wouldn't know what a 13 year old girls twitter page is all about, I don't tend to frequent those sites ...
he's been on the board and an advisor to the company for a while, 2 years f steady declines is more than enough patience .... hurry up and wait ...
just keep the lines of communication open with Schweiterman bobbie, he'll let you know when we are close ...
No more raises bobbie, voted down at AGM, it's time to partner or sell, investors have been very clear with Schweiterman about this